Maximus (NYSE:MMS) CEO Buys $249,078.75 in Stock

Maximus, Inc. (NYSE:MMS) CEO Bruce Caswell bought 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were acquired at an average cost of $78.45 per share, with a total value of $249,078.75. Following the transaction, the chief executive officer owned 328,013 shares in the company, valued at approximately $25,732,619.85. This represents a 0.98% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Maximus Trading Up 1.4%

Shares of MMS stock opened at $74.75 on Friday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $100.00. The firm’s 50 day moving average price is $89.09 and its two-hundred day moving average price is $86.47. The stock has a market cap of $4.08 billion, a price-to-earnings ratio of 11.38 and a beta of 0.57.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, February 13th. Maximus’s payout ratio is presently 20.09%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on MMS shares. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a report on Monday, December 29th. Finally, Wall Street Zen lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. Based on data from MarketBeat.com, Maximus presently has an average rating of “Strong Buy”.

Institutional Investors Weigh In On Maximus

Hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC boosted its stake in shares of Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. Richardson Financial Services Inc. raised its holdings in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 192 shares in the last quarter. Advisory Services Network LLC acquired a new stake in Maximus in the third quarter valued at $32,000. Canada Pension Plan Investment Board bought a new position in Maximus during the 2nd quarter valued at $35,000. Finally, Cullen Frost Bankers Inc. acquired a new position in Maximus during the 3rd quarter worth $38,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.